POLICY |
South Korea Steps Up Stem-Cell Work The South Korean health ministry announced that research into stem cells and regenerative medicine will receive a funding boost of 33 billion won (US $29 million) in 2012, four times that given in 2011. [South Korean Health Ministry, South Korea] Press Release
Stem-Cell Arguments Heard in US Appeals Court A US appeals court heard arguments from lawyers supporting and opposing the US government’s funding for human embryonic stem-cell research, marking another step in what some believe is a slow but steady path to the US Supreme Court. [US Court of Appeals, United States] Press Release
U.S. National Academy Gives Itself a Facelift The U.S. National Academy of Sciences members took a big step toward changing their image by inviting a younger and more diverse group of scientists to join them. [U.S. National Academy of Sciences, United States] Press Release
Universities Clash by the Nile An ambitious scheme to create Egypt’s first science city is finally becoming a reality, but a bitter property dispute is overshadowing enthusiasm for the technology park and university complex. [Egyptian Foundation for Technology Education, Egypt] Press Release |
BUSINESS |
Silence Therapeutics’ Partner, Quark Pharmaceuticals, Extends Its Agreement with Pfizer to Develop One of Its Compounds Containing Silence’s AtuRNAi in a New Indication Silence Therapeutics Plc noted that its partner, Quark Pharmaceuticals, has announced it has amended its existing exclusive Licensing Agreement with Pfizer. [Silence Therapeutics Plc] Press Release
New Fund Established to Stimulate Regenerative Medicine Industry Pfizer Canada and the Centre for Commercialization of Regenerative Medicine (CCRM) have established the Pfizer-CCRM Innovation Fund to accelerate regenerative medicine technologies for drug screening and therapeutic applications. [Marketwire, Incorporated] Press Release
Reinnervate, Roslin Cellab Ally to Develop Protocols for 3-D Growth of hESCs Reinnervate and Roslin Cellab are joining forces to develop protocols for the 3-D growth of human embryonic stem cells (hESCs). Roslin Cellab’s expertise in developing and delivering custom tools and protocols in the field of hESC biology will be coupled with Reinnervate’s Alvetex®Scaffold technology. [Genetic Engineering & Biotechnology News] Press Release
DSM Agrees to Acquire Kensey Nash to Strengthen Its Biomedical Business The purchase by DSM of Kensey Nash will strengthen and complement DSM Biomedical’s business and capabilities, while clearly meeting DSM’s financial and strategic criteria. [Royal DSM] Press Release
The Ludwig Institute for Cancer Research Announces Launch of iTeos Therapeutics SA The Ludwig Institute for Cancer Research announced the launch of a private biotechnology enterprise, iTeos Therapeutics SA, to develop a novel pre-clinical pipeline of immunomodulators to stimulate the immune system’s ability to attack cancer. [Ludwig Institute for Cancer Research Ltd] Press Release
Bio-Matrix Scientific Group, Inc. Announces Newly Formed Stem Cell Subsidiary – Regen BioPharma Inc., Secures $20,000,000 in Institutional Funding Bio-Matrix Scientific Group, Inc. announced it has formed a new subsidiary, Regen BioPharma, Inc. Regen BioPharma has developed a vertically-integrated structure for acquiring patents, performing accelerating preclinical and clinical development, and licensing or selling technology developed to large pharma companies in the area of stem cells. [Marketwire, Incorporated] Press Release
UM’s Interdisciplinary Stem Cell Institute Awarded $10 Million Grant from Starr Foundation The grant will support the University of Miami (UM) Miller School of Medicine’s Interdisciplinary Stem Cell Institute in broadening its preclinical and clinical research on stem cells, and help accelerate its pipeline of translational research and programs for a wide range of debilitating conditions including cardiac disease, cancer, wound healing, stroke, glaucoma and chronic kidney and gastrointestinal diseases. [University of Miami Miller School of Medicine] Press Release
Northwest Bio Awarded $5.5 Million German Government Grant The grant will reimburse fifty percent of the costs for manufacturing in Germany and for Northwest Biotherapeutics, Inc.’s clinical trial with DCVax®-L for brain cancer at up to 30 clinical sites in Germany. [Northwest Biotherapeutics, Inc.] Press Release
Families of SMA Awards New Funding to Advance a CNS Delivered Gene Therapy for Spinal Muscular Atrophy Families of SMA announced the award of up to $750,000 for an important new grant to Dr. Brian Kaspar at Nationwide Children’s Hospital. This award will support preclinical development of a CNS-delivered Gene Therapy for Spinal Muscular Atrophy. [Families of SMA] Press Release
First Fellowships Awarded in New Canadian Stem Cell and Regenerative Medicine Research Program The first two postdoctoral research fellowships of a new program to promote stem cell research in Canada were announced by the program’s sponsors, Canada’s Stem Cell Network and Pfizer. [Stem Cell Network] Press Release
Substantial EU Framework Programme 7 Grant Awarded for Clinical Development of Ark’s Pre-Clinical Product Candidate EG013 in the Treatment of Fetal Growth Restriction Ark Therapeutics Group plc announced it has received notice of the award of an EU Framework Programme 7 Grant of up to €6 million to a consortium led by UCL in which Ark is the sole industrial partner engaged in the research. EG013 is an adenoviral vector containing the vascular endothelial growth factor gene under development by Ark for the treatment of severe fetal growth restriction in pregnant women during the second trimester. [Ark Therapeutics Group plc] Press Release
BioRestorative Therapies Announces Next Generation of Stem Cell Disc Delivery Device BioRestorative Therapies, Inc. announced that the latest version of its stem cell disc delivery device, which is to be used in the treatment of bulging and herniated discs, has shown improvements when compared to earlier versions. [PR Newswire] Press Release
American CryoStem Announces ACS Laboratories Adipose Tissue and Adult Stem Cell Testing Services American CryoStem Corporation announced the launch of its new adipose tissue and adult stem cell testing services to assist physicians involved in tissue engraftment, regenerative medicine procedures and cellular therapies utilizing adult adipose derived stem cells. [American CryoStem Corporation] Press Release
Cryo-Cell International Taps Leader in Stem Cell Therapy to Serve as Chief Scientific Officer Cryo-Cell International, Inc. announced the appointment of Linda Kelley, Ph.D., as chief scientific officer. Dr. Kelley is responsible for overseeing Cryo-Cells state-of-the art laboratory, translational medicine initiatives and quality assurance program at its stem cell and cord blood banking facility in Oldsmar, Florida. [Reuters] Press Release |
JOB OPPORTUNITIES |
Scientist – Induced Pluripotent Stem Cells (STEMCELL Technologies, Inc.)
Scientist – Epithelial Cell Research (STEMCELL Technologies, Inc.)
Scientist – hPSC Bioengineering (STEMCELL Technologies, Inc.)
Scientist – Antibody and Hybridoma Technology Platforms (STEMCELL Technologies, Inc.)
Scientist – Endothelial Cells (STEMCELL Technologies, Inc.)
Research Associate – Chemistry (STEMCELL Technologies, Inc.)
Research Associate – Particle Chemistry (STEMCELL Technologies, Inc.)
Research Technologist – Contract Assay Services (STEMCELL Technologies, Inc.)
Business Analyst – Product Management (STEMSOFT Software, Inc.)
Associate Director, Cell Therapy (Seattle Cancer Care Alliance)
iPSC Scientist Position – Laboratory of Translational Cell Biology (The Bassell Lab, Emory University)
Postdoctoral Position – Translational Breast Cancer Research (ISREC/EPFL)
Senior Scientist (Techshot, Inc.)
Business Development Manager – Stem Cell (SynGen Inc.)
Controller (SynGen Inc.)
Director: Regulatory Affairs (SynGen Inc.)
Manufacturing Manager (SynGen Inc.)
Postdoctoral Fellow – Department of Bioengineering and Barbara Davis Center (University of Colorado at Denver)
Postdoctoral Position – GIGA-Neurosciences (University of Liège)
Postdoctoral Position – Spinal Cord Neural Stem Cells (Institute for Neurosciences of Montpellier)
Cellular Therapy Lab Specialist (The University of Texas Medical School at Houston)
Recruit Top Talent: Reach more than 50,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost. |
|
|
|